STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
26.01
+1.21 (4.88%)
Dec 17, 2025, 3:53 PM EST - Market open
STAAR Surgical Company Employees
STAAR Surgical Company had 1,157 employees as of December 27, 2024. The number of employees increased by 100 or 9.46% compared to the previous year.
Employees
1,157
Change (1Y)
100
Growth (1Y)
9.46%
Revenue / Employee
$199,301
Profits / Employee
-$83,290
Market Cap
1.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 27, 2024 | 1,157 | 100 | 9.46% |
| Dec 29, 2023 | 1,057 | 165 | 18.50% |
| Dec 30, 2022 | 892 | 191 | 27.25% |
| Dec 31, 2021 | 701 | 126 | 21.91% |
| Jan 1, 2021 | 575 | 25 | 4.55% |
| Jan 3, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
STAA News
- 4 hours ago - STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value - Business Wire
- 1 day ago - Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory - Business Wire
- 1 day ago - Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction - Business Wire
- 1 day ago - Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon - Business Wire
- 1 day ago - Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger - Business Wire
- 5 days ago - Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon - Business Wire
- 6 days ago - STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process - Business Wire
- 6 days ago - Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon - Business Wire